Zhongbin Deng

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Dendritic Cells

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Rui Sun, Chao Lei, Zhishan Xu, Xuemei Gu, Liu Huang, Liang Chen, Yi Tan, Min Peng, Kavitha Yaddanapudi, Leah J Siskind, Maiying Kong, Robert A Mitchell, Jun Yan, Zhongbin Deng
Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages. Nature communications 15 (1) (2024)
Rui Sun, Chao Lei, Zhishan Xu, Xuemei Gu, Liu Huang, Liang Chen, Yi Tan, Min Peng, Kavitha Yaddanapudi, Leah J Siskind, Maiying Kong, Robert A Mitchell, Jun Yan, Zhongbin Deng
Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages. Nature communications 15 (1) (2024)
Rui Sun, Chao Lei, Zhishan Xu, Xuemei Gu, Liu Huang, Liang Chen, Yi Tan, Min Peng, Kavitha Yaddanapudi, Leah J Siskind, Maiying Kong, Robert A Mitchell, Jun Yan, Zhongbin Deng
Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages. Nature communications 15 (1) (2024)
Rui Sun, Chao Lei, Zhishan Xu, Xuemei Gu, Liu Huang, Liang Chen, Yi Tan, Min Peng, Kavitha Yaddanapudi, Leah J Siskind, Maiying Kong, Robert A Mitchell, Jun Yan, Zhongbin Deng
Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages. Nature communications 15 (1) (2024)
Rui Sun, Chao Lei, Zhishan Xu, Xuemei Gu, Liu Huang, Liang Chen, Yi Tan, Min Peng, Kavitha Yaddanapudi, Leah J Siskind, Maiying Kong, Robert A Mitchell, Jun Yan, Zhongbin Deng
Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages. Nature communications 15 (1) (2024)
Rui Sun, Chao Lei, Liang Chen, Liqing He, Haixun Guo, Xiang Zhang, Wenke Feng, Jun Yan, Craig J McClain, Zhongbin Deng
Alcohol-driven metabolic reprogramming promotes development of RORγt-deficient thymic lymphoma. Oncogene 41 (16) (2022)